ARCHIVES

EntreMed Begins Pilot Phase II Trial Of Small Molecule Angiogenesis Inhibitor.

This article is from The Cancer Letter archive.

Vol. 26 No. 46 | December 15, 2000

Download PDF Visit The Full Archive

Related Articles

NIH Funds 11 New Grants In Women’s Health Research.

September 29, 2000

ECOG, ACRIN Agree To Join; NCI’s Goal Of Four Adult Groups Is One Merger Away

March 18, 2011

New Diet Trial Is Described In Concept

October 26, 1990

Kimes Heads NCI Organ Systems Committee; Changes Being Implemented

April 1, 1988

Gonzalez-Angulo To Serve 10 Years In Poisoning Case

October 3, 2014

Colon Cancer Survival Rates Differ Across Racial Lines

October 28, 2011